INBX

Inhibrx Biosciences, Inc. is a clinical-stage biotechnology company based in La Jolla, California, dedicated to the development of innovative biological therapeutics targeting cancer and other critical diseases. The company's robust pipeline includes a range of monoclonal antibodies and multi-specific therapeutics designed to optimize treatment efficacy and safety, thereby enhancing patient outcomes. Leveraging its proprietary technologies, Inhibrx stands out in the rapidly evolving biotech landscape, presenting an attractive opportunity for institutional investors interested in next-generation therapeutic advancements.